Advertisement
GNPX vs OTLK
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GNPX is a Hold and OTLK is a StrongBuy.
GNPX saw its Stochastic Oscillator recovers from the overbought zone
The Stochastic Oscillator for GNPX moved out of overbought territory on November 06, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 32 similar instances where the indicator exited the overbought zone. In 31 of the 32 cases the stock moved lower. This puts the odds of a downward move at 90%.
Technical Analysis (Indicators)
Bearish Trend Analysis
Following a 3-day decline, the stock is projected to fall further. Considering past instances where GNPX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Aroon Indicator for GNPX entered a downward trend on November 05, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where GNPX's RSI Oscillator exited the oversold zone, 39 of 44 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 89%.
The Momentum Indicator moved above the 0 level on October 30, 2026. You may want to consider a long position or call options on GNPX as a result. In 57 of 71 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 80%.
Following a +11.16% 3-day Advance, the price is estimated to grow further. Considering data from situations where GNPX advanced for three days, in 152 of 199 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.
GNPX may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
Fundamental Analysis (Ratings)
The Tickeron Valuation Rating of 49 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.115) is normal, around the industry mean (3.498). P/E Ratio (0.060) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (440.869).
The Tickeron PE Growth Rating for this company is 84 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 92 (best 1 - 100 worst), indicating slightly worse than average price growth. GNPX’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. GNPX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
OTLK in upward trend: price may ascend as a result of having broken its lower Bollinger Band on October 14, 2026
OTLK may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 32 of 34 cases where OTLK's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 90%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where OTLK's RSI Indicator exited the oversold zone, 25 of 30 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 83%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 52 of 66 cases where OTLK's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 79%.
The Moving Average Convergence Divergence (MACD) for OTLK just turned positive on November 10, 2026. Looking at past instances where OTLK's MACD turned positive, the stock continued to rise in 35 of 43 cases over the following month. The odds of a continued upward trend are 81%.
Following a +4.72% 3-day Advance, the price is estimated to grow further. Considering data from situations where OTLK advanced for three days, in 201 of 243 cases, the price rose further within the following month. The odds of a continued upward trend are 83%.
Bearish Trend Analysis
The Momentum Indicator moved below the 0 level on October 29, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on OTLK as a result. In 79 of 95 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 83%.
The 50-day moving average for OTLK moved below the 200-day moving average on October 19, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where OTLK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 85%.
The Aroon Indicator for OTLK entered a downward trend on November 11, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 11 (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (-10.223) is normal, around the industry mean (3.498). P/E Ratio (-0.623) is within average values for comparable stocks, (-1.193). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (9.059). Dividend Yield (0.000) settles around the average of (130.981) among similar stocks. P/S Ratio (128.205) is also within normal values, averaging (440.869).
The Tickeron Price Growth Rating for this company is 63 (best 1 - 100 worst), indicating steady price growth. OTLK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OTLK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.
GNPX | OTLK | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 58 | 12 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 49 Fair valued | 11 Undervalued | |
PROFIT vs RISK RATING 1..100 | 100 | 100 | |
SMR RATING 1..100 | 100 | 100 | |
PRICE GROWTH RATING 1..100 | 92 | 63 | |
P/E GROWTH RATING 1..100 | 84 | 7 | |
SEASONALITY SCORE 1..100 | 28 | 75 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
OTLK's Valuation (11) in the Biotechnology industry is somewhat better than the same rating for GNPX (49) in the Pharmaceuticals Major industry. This means that OTLK’s stock grew somewhat faster than GNPX’s over the last 12 months.
OTLK's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as GNPX (100) in the Pharmaceuticals Major industry. This means that OTLK’s stock grew similarly to GNPX’s over the last 12 months.
OTLK's SMR Rating (100) in the Biotechnology industry is in the same range as GNPX (100) in the Pharmaceuticals Major industry. This means that OTLK’s stock grew similarly to GNPX’s over the last 12 months.
OTLK's Price Growth Rating (63) in the Biotechnology industry is in the same range as GNPX (92) in the Pharmaceuticals Major industry. This means that OTLK’s stock grew similarly to GNPX’s over the last 12 months.
OTLK's P/E Growth Rating (7) in the Biotechnology industry is significantly better than the same rating for GNPX (84) in the Pharmaceuticals Major industry. This means that OTLK’s stock grew significantly faster than GNPX’s over the last 12 months.
| GNPX | OTLK | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 89% | 1 day ago 83% |
| Stochastic ODDS (%) | 1 day ago 90% | 1 day ago 79% |
| Momentum ODDS (%) | 1 day ago 80% | 1 day ago 83% |
| MACD ODDS (%) | N/A | 1 day ago 81% |
| TrendWeek ODDS (%) | 1 day ago 78% | 1 day ago 84% |
| TrendMonth ODDS (%) | 1 day ago 90% | 1 day ago 85% |
| Advances ODDS (%) | 1 day ago 76% | 1 day ago 83% |
| Declines ODDS (%) | 3 days ago 90% | 6 days ago 85% |
| BollingerBands ODDS (%) | 1 day ago 90% | 1 day ago 90% |
| Aroon ODDS (%) | 1 day ago 90% | 1 day ago 85% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GNPX’s FA Score shows that 0 FA rating(s) are green while OTLK’s FA Score has 2 green FA rating(s).
- GNPX’s FA Score: 0 green, 5 red.
- OTLK’s FA Score: 2 green, 3 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
GNPX’s TA Score shows that 4 TA indicator(s) are bullish while OTLK’s TA Score has 5 bullish TA indicator(s).
- GNPX’s TA Score: 4 bullish, 3 bearish.
- OTLK’s TA Score: 5 bullish, 4 bearish.
Price Growth
GNPX (@Biotechnology) experienced а +7.01% price change this week, while OTLK (@Biotechnology) price change was +4.09% for the same time period.
The average weekly price growth across all stocks in the @Biotechnology industry was -0.49%. For the same industry, the average monthly price growth was -6.84%, and the average quarterly price growth was -13.86%.
Reported Earning Dates
GNPX is expected to report earnings on Nov 13, 2026.
OTLK is expected to report earnings on Dec 18, 2026.
Industries' Descriptions
@Biotechnology (-0.49% weekly)Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.
Advertisement
GNPX and
Correlation & Price change
A.I.dvisor indicates that over the last year, GNPX has been closely correlated with CANF. These tickers have moved in lockstep 93% of the time. This A.I.-generated data suggests there is a high statistical probability that if GNPX jumps, then CANF could also see price increases.
| Ticker / NAME | Correlation To GNPX | 1D Price Change % | ||
|---|---|---|---|---|
| GNPX | 100% | +9.57% | ||
| CANF - GNPX | 93% Closely correlated | -6.63% | ||
| APVO - GNPX | 86% Closely correlated | -29.63% | ||
| ICU - GNPX | 82% Closely correlated | +1.05% | ||
| MLEC - GNPX | 76% Closely correlated | N/A | ||
| LONA - GNPX | 76% Closely correlated | -3.48% | ||
More | ||||
OTLK and
Correlation & Price change
A.I.dvisor indicates that over the last year, OTLK has been loosely correlated with APVO. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if OTLK jumps, then APVO could also see price increases.
| Ticker / NAME | Correlation To OTLK | 1D Price Change % | ||
|---|---|---|---|---|
| OTLK | 100% | +4.43% | ||
| APVO - OTLK | 45% Loosely correlated | -29.63% | ||
| ICU - OTLK | 36% Loosely correlated | +1.05% | ||
| GNPX - OTLK | 34% Loosely correlated | +9.57% | ||
| CYTK - OTLK | 33% Loosely correlated | +4.18% | ||
| PDSB - OTLK | 33% Loosely correlated | -0.97% | ||
More | ||||